Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Shares Outstanding (Diluted Average) (2021 - 2026)

TriSalus Life Sciences has reported Shares Outstanding (Diluted Average) over the past 6 years, most recently at $52.3 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) rose 83.38% year-over-year to $52.3 million; the TTM value through Mar 2026 reached $52.3 million, up 83.38%, while the annual FY2025 figure was $37.9 million, 49.61% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $52.3 million at TriSalus Life Sciences, up from $37.9 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $52.3 million in Q1 2026 and troughed at $309609.0 in Q4 2022.
  • A 5-year average of $20.8 million and a median of $23.6 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 98.31% in 2023 and later skyrocketed 5497.4% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $309609.0 in 2022, then soared by 2934.71% to $9.4 million in 2023, then skyrocketed by 169.61% to $25.3 million in 2024, then skyrocketed by 49.61% to $37.9 million in 2025, then soared by 38.04% to $52.3 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for TLSI at $52.3 million in Q1 2026, $37.9 million in Q4 2025, and $34.9 million in Q3 2025.